Japan initiates market authorization of weight-loss drug semaglutide under universal health coverage, but with stringent prescription restrictions. | Pepdox
Japan initiates market authorization of weight-loss drug semaglutide under universal health coverage, but with stringent prescription restrictions.
Diabetes, obesity & metabolism20244 citationsPMID: 38747140